Posts

Adherium agreement signed with Dulcian Health for US remote patient monitoring

Melbourne, Australia Link here – 9 September 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote patient monitoring and data management solutions, is pleased to announce a partnership agreement with Dulcian Health (“Dulcian”) to deploy the Hailie® platform enabling doctors and medical groups in the US to access reimbursement […]

Adherium to present at Reach Markets ‘Meet the CEOs’ live event

Melbourne, Australia / Link here – 16 August 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce its participation in the Reach Markets ‘Meet the CEOs’ live event, being held tomorrow, Wednesday 17th of August 2022. The webinar will open […]

Humanetix – How prepared are you for AN-ACC?

Link Here – As ACFI will be replaced AN-ACC from October 2022, the focus on quality data, systems and interoperability cannot be overlooked. With AN-ACC focusing on individual care needs, providers will need to scramble to obtain client care delivery data with the process between shadow assessments, AN-ACC tools, and ultimately funding delivery to […]

Adherium submits FDA 510(k) application for next generation Hailie sensor for GSK pMDI inhalers

Melbourne, Australia – 2 August 2022 link here: Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced submission to the US Food and Drug Administration (FDA) of its 510(k) clearance to market application, which connects GlaxoSmithKline® (GSK) Ventolin®, Advair®, and Flovent® pressurized metered-dose inhaler (pMDI) users […]

Parkinson’s patients benefit from revolutionary watch on the NHS to manage care at home

Link to full article Patients with Parkinson’s disease are being given life-changing smart watches that allow doctors to remotely assess their condition in a pioneering project to revolutionise NHS care. The cutting-edge gadget containing sensors, known as a Parkinson’s Kinetigraph (PKG), is worn around the clock for six days to monitor patients’ movements at home. […]

Arlington woman first in Texas to get smart knee replacement

Arlington Woman First in Texas to Get ‘Smart Knee’ Replacement The Bluetooth-enabled implant allows doctors and patients to track their recovery from a knee replacement through a smartphone app By Bianca Castro • Published May 2, 2022 • Updated on May 2, 2022 at 5:55 pm NBCUniversal, Inc.  An Arlington woman is the first in Texas to receive what’s called a “smart knee” […]

Adherium Releases Next Generation Respiratory Platform Integration Services

Link to full article Melbourne, Australia – 28 April 2022: Adherium (ASX: ADR), a leader in respiratory eHealth, remote monitoring, and data management solutions, announces the release of the latest Hailie® platform integration tools comprised of an advanced Rest application programming interface (API) and a new, updated software development kit (SDK) to improve connection with […]

Adherium appoints Vice President of Global Business Development to drive commercial growth

Link to full article Melbourne, Australia – 22 April 2022: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce it has significantly strengthened its international commercial leadership team with the appointment of Mr Francis White as Vice President of Global Business Development based in the […]

Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain

Link to full article Artarmon, Australia – March 8, 2022 – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced it received full approval from the United States Food and […]

Saluda Medical Announces $125M Equity Financing Led Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.

Link to full article March 2, 2022 – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies designed to treat debilitating neurological disorders, earlier this quarter finalized US $125 million in equity financing, led existing investor Redmile […]